Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

2,600.00p
   
  • Change Today:
      20.00p
  • 52 Week High: 2,950.00
  • 52 Week Low: 1,677.50
  • Currency: UK Pounds
  • Shares Issued: 5.14m
  • Volume: 1,079
  • Market Cap: 133.61m

Bioventix Overview

Bioventix is in the pharma and biotech sector and is currently trading at 2,600.00p per share. In the last year Bioventix's share price has ranged from 1,677.50p to 2,950.00p.

1 Day Chart (19-04-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 2.0% 2.5%
Div Cover 1.9 1.6
Op Mrgn 78.9% 78.8%
ROCE 56.2%  
Latest F'cast
P/E 27.0 26.2
PEG 0.7 8.9
Pr/Revenue 18.4 16.7
Pr/Book 13.2  
Latest F'cast
Revenue 31.3% 10.3%
PBT 36.7% 9.2%
EPS 39.3% 2.9%
DPS 20.0% 25.5%

Bioventix Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-14 3.54 2.23 36.09p 16.8 n/a n/a 32.60p 5.4%
30-Jun-15 4.33 3.11 50.66p 17.3 0.4 +40% 32.60p 3.7%
30-Jun-16 5.52 4.22 69.18p 13.9 0.4 +37% 42.50p 4.4%
30-Jun-17 7.25 5.77 96.36p 19.8 0.5 +39% 51.00p 2.7%

Bioventix Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 8.00 6.30 99.20p 26.2 8.9 +3% 64.00p 2.5%
30-Jun-19 8.00 6.30 100.10p 26.0 28.7 +1% 73.00p 2.9%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Bioventix Plc - Holding(s) in Company 12-Apr-2018 11:38 PR Newswire
Bioventix Plc - Half-year Report 26-Mar-2018 07:00 PR Newswire
Bioventix Plc - Holding(s) in Company 13-Feb-2018 10:29 PR Newswire

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,600.00p
Change Today 20.00p
% Change 0.78 %
52 Week High 2,950.00
52 Week Low 1,677.50
Volume 1,079
Shares Issued 5.14m
Market Cap 133.61m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.15% below the market average96.15% below the market average96.15% below the market average96.15% below the market average96.15% below the market average
90.32% below the sector average90.32% below the sector average90.32% below the sector average90.32% below the sector average90.32% below the sector average
Price Trend
86.44% above the market average86.44% above the market average86.44% above the market average86.44% above the market average86.44% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Income
42.75% below the market average42.75% below the market average42.75% below the market average42.75% below the market average42.75% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
90.07% above the market average90.07% above the market average90.07% above the market average90.07% above the market average90.07% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Apr-18 26-Oct-17
Paid 20-Apr-18 10-Nov-17
Amount 25.00p 31.00p

Trades for 19-Apr-2018

Time Volume / Share Price
16:29 681 @ 2,650.00p
14:41 10 @ 2,570.00p
14:05 190 @ 2,570.00p
11:00 50 @ 2,600.00p
10:37 148 @ 2,630.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner

Top of Page